Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -9.55x is 28% above its 5-year average of -13.19x, near the high end of its 5-year range (-17.06x–-7.73x).
13.75% above its 12-month average of -11.07x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -11.63x.
INTEREST COVERAGE RATIO
-9.55x
INTEREST COVERAGE RATIO AVG TTM
-11.07x
INTEREST COVERAGE RATIO AVG 3Y
-12.36x
INTEREST COVERAGE RATIO AVG 5Y
-13.19x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+13.75%
CURRENT VS 3Y AVG
+22.73%
CURRENT VS 5Y AVG
+27.60%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.79x
median of 488 covered companies
CURRENT VS SECTOR MEDIAN
-64.94%
vs the sector median at left
Humacyte, Inc.
Market Cap
$84.25M
Interest Coverage Ratio
-9.55x
TTM Avg
-11.07x
3Y Avg
-12.36x
5Y Avg
-13.19x
Market Cap
$83.76M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$84.54M
Interest Coverage Ratio
-3676.85x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$82.85M
Interest Coverage Ratio
N/A
TTM Avg
26.56x
3Y Avg
26.56x
5Y Avg
26.56x
Market Cap
$81.86M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$86.90M
Interest Coverage Ratio
40.06x
TTM Avg
25.10x
3Y Avg
22.17x
5Y Avg
18.57x
Market Cap
$87.20M
Interest Coverage Ratio
9.46x
TTM Avg
9.46x
3Y Avg
9.46x
5Y Avg
9.46x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Humacyte, Inc. (HUMA) | $84.25M | -9.55x | -11.07x | -12.36x | -13.19x |
| ProMIS Neurosciences, Inc. (PMN)vs › | $83.76M | N/A | N/A | N/A | N/A |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.54M | -3676.85x | N/A | N/A | N/A |
| Cardiff Oncology, Inc. (CRDF)vs › | $82.85M | N/A | 26.56x | 26.56x | 26.56x |
| LENSAR Inc (LNSR)vs › | $82.78M | N/A | N/A | N/A | N/A |
| MediciNova, Inc. (MNOV)vs › | $82.45M | N/A | N/A | N/A | N/A |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $81.86M | N/A | N/A | N/A | N/A |
| CareCloud, Inc. (CCLD)vs › | $86.90M | 40.06x | 25.10x | 22.17x | 18.57x |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $87.20M | 9.46x | 9.46x | 9.46x | 9.46x |
| Nutriband Inc. (NTRB)vs › | $80.78M | -369.11x | N/A | N/A | N/A |
Interest Coverage
-9.6x
Debt/Equity
2.12
Current Ratio
6.21
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -11.63x |
| 2026-03-31 | -12.74x |
| 2025-12-31 | -9.97x |
| 2025-09-30 | -9.34x |
| 2025-06-30 | -11.68x |
| 2025-03-31 | -7.73x |
| 2024-12-31 | -11.20x |
| 2024-09-30 | -12.40x |
| 2024-06-30 | -11.73x |
| 2024-03-31 | -14.64x |
| 2023-12-31 | -15.16x |
| 2023-09-30 | -16.83x |
| 2023-06-30 | -15.63x |
| 2023-03-31 | -13.25x |
| 2022-12-31 | -12.68x |
| 2022-09-30 | -14.32x |
| 2022-06-30 | -12.45x |
| 2022-03-31 | -15.20x |
| 2021-12-31 | -15.49x |
| 2021-09-30 | -17.06x |
| 2021-06-30 | -15.86x |
| 2021-03-31 | -37.09x |
| 2020-12-31 | -28.97x |
| 2020-09-30 | -31.35x |
